← All trials
NCT00121446
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2003
- Primary completion
- —
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 300
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- University of AlbertaLead sponsor
- RocheCollaborator
- Canadian VIGOUR CentreStudy chair
- SanofiCollaborator
- Eli LillyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.